GlassScriptPhysician profile
Edgar Garcia
NPI 1649677139
$16,616.34
in general payments reported to CMS, 2019-2025
57 companies · $2,805 in 2025
The $2,805 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,415 · 2022: $3,595 · 2023: $3,632 · 2024: $3,169 · 2025: $2,805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,605.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,977.76 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,875.80 | 2021-2025 | Evenity, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,805.45 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $1,703.35 | 2021-2025 | |
| Lilly USA, LLC | $1,250.67 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $638.75 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $621.24 | 2021-2025 | Xifaxan, Trulance |
| Abiomed | $414.92 | 2024 | Impella |
| Antares Pharma, INC. | $399.28 | 2021-2024 | Xyosted, Nocdurna, Tlando |
| Dexcom, INC. | $387.03 | 2021-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Amarin Pharma, INC. | $353.05 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $310.10 | 2021-2023 | Belsomra, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.71 | 2021-2025 | Jardiance, Ofev |
| Biohaven Pharmaceutical Holding Company LTD. | $301.45 | 2022 | |
| Ironwood Pharmaceuticals, INC | $256.93 | 2021-2024 | Linzess |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $239.33 | 2021-2024 | Livalo, Seglentis |
| Paratek Pharmaceuticals, INC. | $211.00 | 2023-2025 | Nuzyra |
| Phathom Pharmaceuticals, INC. | $201.03 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $199.80 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Sumitomo Pharma America, INC. | $181.74 | 2024-2025 | Gemtesa |
| Biohaven Pharmaceuticals, INC. | $181.65 | 2021 | |
| Esperion Therapeutics, INC. | $179.34 | 2021-2024 | Nexletol |
| Intuity Medical INC | $176.98 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Astellas Pharma US INC | $157.23 | 2021-2025 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $155.63 | 2021-2025 | |
| Abbott Laboratories | $154.23 | 2021-2024 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $146.02 | 2022-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $145.84 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $145.66 | 2021-2023 | |
| Urovant Sciences INC | $144.05 | 2022 | |
| Janssen Pharmaceuticals, INC | $134.02 | 2022-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $121.71 | 2021-2023 | Trintellix |
| Boston Scientific Corporation | $119.80 | 2024-2025 | Ekosonic, Amplatz Super Stiff, Ranger |
| Horizon Therapeutics Plc | $105.84 | 2022 | |
| Eisai INC. | $102.52 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $84.58 | 2022 | |
| Exact Sciences Corporation | $74.73 | 2023-2025 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $65.98 | 2021 | |
| Radius Health, INC. | $60.97 | 2024-2025 | Tymlos |
| Nevro Corp. | $53.79 | 2024 | Senza |
| Madrigal Pharmaceuticals | $46.83 | 2025 | Rezdiffra |
| Phadia US INC. | $46.78 | 2024 | Immunocap |
| Arbor Pharmaceuticals, INC. | $40.47 | 2021 | |
| Sanofi Pasteur INC. | $35.42 | 2023-2025 | |
| Halozyme INC | $33.46 | 2023 | |
| Biogen, INC. | $32.04 | 2021 | |
| Stryker Corporation | $31.67 | 2022 | |
| Redhill Biopharma INC. | $30.32 | 2021-2022 | |
| Corcept Therapeutics | $26.70 | 2024 | Korlym |
| Seqirus USA INC | $24.52 | 2025 | Flucelvax, Fluad |
| Optinose US, INC. | $20.30 | 2023 | |
| Corium, LLC | $19.81 | 2024 | Azstarys |
| Averitas Pharma INC. | $18.08 | 2024 | Qutenza |
| Allergan, INC. | $17.79 | 2021 | |
| Inspire Medical Systems, INC. | $16.71 | 2025 | Inspire |
| Tris Pharma INC | $16.01 | 2023 | Dyanavel Xr |
| Genentech USA, INC. | $15.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.